Iceland· IS-IS/1/15/001/02
Aripiprazol Krka
A aripiprazole product containing aripiprazolum inn, registered in Iceland by Krka, d.d., Novo mesto. The same ATC class is registered in 18 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Aripiprazole is registered in 18 of 19 countries.
Countries holding a registration under ATC N05AX12 (aripiprazole), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 11 of them publish a price we can compare per daily dose
Aripiprazole · ATC N05AX12
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of aripiprazole costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in United States to $3.12 in Switzerland — a ×21 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Aripiprazole · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.12
- IT Italy$1.19
- FR France$1.06
- US United States$0.15 (acquisition cost)
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Aripiprazolum INN
- Manufacturer
- Krka, d.d., Novo mesto
- Country
- Iceland (IS)
- ATC code
- N05AX12
- ATC class
- Aripiprazole
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean10765756 stk x1 þpakkiISK 4098
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
468 interactions on record for aripiprazole.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aripiprazole · interactions on record
468 records
- 11 severe
- 339 moderate
- 2 minor
- 67 info
Most severe, free to view
- MetoclopramideA03FA01severe
- ClotrimazoleA01AB18moderate
- CimetidineA02BA01moderate
- FamotidineA02BA03moderate
49 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aripiprazole in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABILIFYOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- United StatesABILIFYOtsuka America Pharmaceutical, Inc.
- SpainABEPAX 10 MG COMPRIMIDOS EFGUxa Farma S.A.
- United KingdomAbilify 10mg tabletsDE Pharmaceuticals
- PolandAbilifyOtsuka Pharmaceutical Netherlands B.V.
- NetherlandsAbilify 10 mg, tablettenOtsuka Pharmaceutical Netherlands B.V.
- FranceABILIFY 10 mg, compriméOTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)
- SwedenAbilify 10 mg Munsönderfallande tablettOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · 300 Mg, Arileto
- Belgium · Aripiprazol Krka, Aripiprazol Sandoz
- Bulgaria · Абизол, Арикоган
- Cyprus · Aripiprazole Aurobindo, Aripiprazole Krka
- Czechia · Abyca, Aricogan
- Germany · Aripipan, Aripiprazol 1 A Pharma
- Denmark · Aripiprazol Krka, Aripiprazol Stada
- Estonia · Aregzilap, Aripiprazole Stada
- Spain · Abik, Abilium
- Finland · Aripiprazol Krka, Aripiprazol Stada
- France · Aripiprazole Almus, Aripiprazole Arrow
- United Kingdom (Northern Ireland) · Aripiprazole, Aripiprazole Accord-Uk
- Greece · Abelfiz, Aripility
- Croatia · Aregzilap, Aripiprazol Pliva
- Hungary · Aripiprazol Sandoz, Aripiprazol Stada
- Ireland · Aripiprazole Brillpharma (Ireland), Aripiprazole Clonmel
- Italy · Aberipra, Aripiprazolo Alter
- Liechtenstein · Abilify, Abilify Maintena
- Lithuania · Aregzilap, Aripiprazole Stada
- Luxembourg · Aripiprazol Ratiopharm, Aripiprazole Eg
- Latvia · Aregzilap, Aripiprazole Acino
- Malta · Aripiprazol Generis, Aripiprazole Ascend
- Netherlands · Aribit Odt, Aricogan
- Norway · Abilify, Abilify Maintena
- Poland · Abilium, Apiprax
- Portugal · Aripiprazol Altedron, Aripiprazol Alter
- Romania · Aripiprazol Accord Healthcare, Aripiprazol Stada
- Sweden · Aregzilap, Aripiprazol Krka
- Slovenia · Aripiprazol Accord Healthcare, Aripiprazol Stada
- Slovakia · Aripiprazol Sandoz, Aripiprazol Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8c95c53-21fe-48e9-84e5-8aeee82229e8 GET /v1/drugs/e8c95c53-21fe-48e9-84e5-8aeee82229e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tafla",
"source": "lyfjastofnun",
"atc_raw": "N05AX12",
"marketed": true,
"strength": "10 mg",
"ma_number": "IS/1/15/001/02",
"substance": "Aripiprazolum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "42030"
}See everything about aripiprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.